ARVINAS INC. - COMMON STOCK
7.6300
05-May-25 20:45:00
15 minutes delayed
Stocks
-0.0900
-1.17%
Today's range
7.3300 - 7.9100
ISIN
N/A
Source
NASDAQ
-
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
01 May 2025 07:00:24 By Nasdaq GlobeNewswire
-
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
28 Apr 2025 07:00:00 By Nasdaq GlobeNewswire
-
28 Apr 2025 06:45:37 By Nasdaq GlobeNewswire
-
23 Apr 2025 10:44:25 By Nasdaq GlobeNewswire
-
21 Apr 2025 07:00:54 By Nasdaq GlobeNewswire
-
04 Apr 2025 07:00:08 By Nasdaq GlobeNewswire
-
27 Mar 2025 07:00:24 By Nasdaq GlobeNewswire
-
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
11 Mar 2025 06:45:00 By Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
04 Mar 2025 16:05:09 By Nasdaq GlobeNewswire
-
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
11 Feb 2025 07:00:04 By Nasdaq GlobeNewswire
-
Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
03 Feb 2025 07:00:49 By Nasdaq GlobeNewswire
-
10 Jan 2025 07:00:19 By Nasdaq GlobeNewswire
-
10 Dec 2024 09:05:00 By Nasdaq GlobeNewswire
-
Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference
27 Nov 2024 07:00:31 By Nasdaq GlobeNewswire
-
25 Nov 2024 17:35:18 By Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
04 Nov 2024 07:00:13 By Nasdaq GlobeNewswire
-
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
30 Oct 2024 07:00:45 By Nasdaq GlobeNewswire
-
Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day
22 Oct 2024 16:05:06 By Nasdaq GlobeNewswire
-
21 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
Arvinas to Participate in Upcoming Investor Conferences
29 Aug 2024 07:00:48 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >